ES2969979T3 - Métodos para detectar enfermedad renal - Google Patents

Métodos para detectar enfermedad renal Download PDF

Info

Publication number
ES2969979T3
ES2969979T3 ES18196516T ES18196516T ES2969979T3 ES 2969979 T3 ES2969979 T3 ES 2969979T3 ES 18196516 T ES18196516 T ES 18196516T ES 18196516 T ES18196516 T ES 18196516T ES 2969979 T3 ES2969979 T3 ES 2969979T3
Authority
ES
Spain
Prior art keywords
kidney disease
methods
disclosure
kidney
gfr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES18196516T
Other languages
English (en)
Inventor
Mahalakshmi Yerramilli
Murthy V S N Yerramilli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Idexx Laboratories Inc
Original Assignee
Idexx Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52628954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2969979(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idexx Laboratories Inc filed Critical Idexx Laboratories Inc
Application granted granted Critical
Publication of ES2969979T3 publication Critical patent/ES2969979T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La divulgación está dirigida a métodos y aparatos para la determinación, diagnóstico, progresión y pronóstico de la enfermedad renal y la mortalidad asociada con la enfermedad renal. La divulgación incluye un método para determinar la función renal, en particular estimar la tasa de filtración glomerular (TFG), en un animal. La TFG puede ser útil en el diagnóstico y tratamiento de enfermedades o disfunciones renales. En diversos aspectos, la divulgación se dirige al uso de dimetilarginina simétrica libre (SDMA) y creatinina en muestras de sangre de animales, en particular gatos y perros, para determinar la tasa de filtración glomerular y la enfermedad renal. (Traducción automática con Google Translate, sin valor legal)
ES18196516T 2013-09-05 2014-09-05 Métodos para detectar enfermedad renal Active ES2969979T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361874011P 2013-09-05 2013-09-05

Publications (1)

Publication Number Publication Date
ES2969979T3 true ES2969979T3 (es) 2024-05-23

Family

ID=52628954

Family Applications (2)

Application Number Title Priority Date Filing Date
ES18196516T Active ES2969979T3 (es) 2013-09-05 2014-09-05 Métodos para detectar enfermedad renal
ES14842603T Active ES2746008T3 (es) 2013-09-05 2014-09-05 Métodos para detectar enfermedad renal

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES14842603T Active ES2746008T3 (es) 2013-09-05 2014-09-05 Métodos para detectar enfermedad renal

Country Status (20)

Country Link
US (2) US11035861B2 (es)
EP (3) EP3041576B1 (es)
JP (4) JP6657096B2 (es)
KR (2) KR102273028B1 (es)
CN (1) CN105705202B (es)
AU (2) AU2014315063B2 (es)
CA (2) CA2923140C (es)
CY (1) CY1123179T1 (es)
DK (1) DK3041576T3 (es)
ES (2) ES2969979T3 (es)
HR (1) HRP20191569T1 (es)
HU (1) HUE045723T2 (es)
LT (1) LT3041576T (es)
MX (2) MX2016002922A (es)
NZ (1) NZ717554A (es)
PL (1) PL3041576T3 (es)
PT (1) PT3041576T (es)
RS (1) RS59287B1 (es)
SI (1) SI3041576T1 (es)
WO (1) WO2015035155A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015035155A1 (en) 2013-09-05 2015-03-12 Idexx Laboratories, Inc. Methods for detecting renal disease
KR102492243B1 (ko) 2015-02-20 2023-01-25 아이덱스 래보러토리즈, 인코포레이티드 배경 신호에 대한 보상에 의한 균질 면역검정
WO2016176691A1 (en) * 2015-04-30 2016-11-03 Idexx Laboratories, Inc. Methods for detecting renal disease
CA3063424A1 (en) 2017-05-31 2018-12-06 Mars, Incorporated Methods of diagnosing and treating chronic kidney disease
CA3072427C (en) 2017-08-08 2023-12-05 Fresenius Medical Care Holdings, Inc. Systems and methods for treating and estimating progression of chronic kidney disease
KR20200073259A (ko) * 2017-10-19 2020-06-23 아이덱스 래보러토리즈, 인코포레이티드 대칭 디메틸아르기닌의 검출
US20210373031A1 (en) * 2018-10-17 2021-12-02 Kagami Inc. Method for determining glomerular filtration ability
CN109545377B (zh) * 2018-10-22 2021-11-23 中南大学湘雅三医院 获取肾小球滤过率的模型的建立方法
US10745492B1 (en) * 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof
EP4025301A4 (en) * 2019-09-05 2023-07-19 The Regents of the University of California NON-INVASIVE METHOD FOR QUANTIFYING KIDNEY FUNCTION AND FUNCTIONAL DECLINE
JP6993654B2 (ja) * 2019-12-27 2022-02-15 Kagami株式会社 腎機能を推定する方法及びシステム
CN112768073B (zh) * 2021-01-15 2023-04-18 中山大学附属第三医院 一种肾小球滤过率估计模型的构建方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134787A1 (de) * 1981-09-02 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Creatinin-antikoerper
US4818703A (en) 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination
EP0356160A3 (en) 1988-08-24 1991-09-11 The Board Of Trustees Of The Leland Stanford Junior University Capillary device
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6455288B1 (en) 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
US5804452A (en) * 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
WO1998049199A1 (en) 1997-05-01 1998-11-05 Panorama Research, Inc. Cardiovascular disease risk assessment
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6358699B1 (en) 1999-02-05 2002-03-19 Cooke Pharma Assay for asymmetrical NG, NG dimethyl-l-arginine
WO2001046221A1 (en) 1999-12-22 2001-06-28 The Research Foundation Of State University Of New York Protein methylarginine-specific antibodies
WO2002004465A1 (en) 2000-07-06 2002-01-17 Fal Diagnostics Methods and kits for the detection of arginine compounds
EP1301790B1 (en) * 2000-07-12 2008-04-09 Naser, Werner, Dr. Direct assessment of analyte to reference molecule ratios
DE10040904A1 (de) 2000-08-18 2002-02-28 Boeger Rainer H Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
US7241856B2 (en) 2003-06-02 2007-07-10 Pentron Clinical Technologies Llc Dental resins, dental composite materials, and method of manufacture thereof
JP4214271B2 (ja) 2002-10-15 2009-01-28 アークレイ株式会社 クレアチニン測定用試験片
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
WO2004046314A2 (en) 2002-11-15 2004-06-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for detecting asymmetric dimethylarginine in a biological sample
US20050148029A1 (en) 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
ES2332218T3 (es) 2004-11-04 2010-01-29 Germediq Forschungs- Und Entwicklungsgesellschaft Mbh Metodo para la determinacion de arginina, argininas metiladas y sus derivados.
US8725990B1 (en) 2004-11-15 2014-05-13 Nvidia Corporation Configurable SIMD engine with high, low and mixed precision modes
WO2006078813A2 (en) 2005-01-21 2006-07-27 Biosite Incorporated Arginine analogs, and methods for their synthesis and use
JP2007176872A (ja) 2005-12-28 2007-07-12 Sentan Seimei Kagaku Kenkyusho:Kk アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
EP2229452B1 (en) 2007-12-05 2015-07-29 King's College London Method for aiding the diagnosis of a disorder
EP3808733A1 (en) * 2008-08-07 2021-04-21 IDEXX Laboratories, Inc. Methods for detecting symmetrical demethylarginine
ES2499415T3 (es) * 2009-06-02 2014-09-29 Biocrates Life Sciences Ag Nuevos biomarcadores para la evaluación de enfermedades renales
CN101587118B (zh) * 2009-07-03 2012-09-12 长春迪瑞医疗科技股份有限公司 肌酐尿液分析试纸及制备方法
CN101598727B (zh) * 2009-07-09 2012-10-10 上海科华生物工程股份有限公司 定量测定人体血液尿素含量的干化学试纸
CN101865911A (zh) * 2010-03-16 2010-10-20 苏州市玮琪生物科技有限公司 一种尿肌酐定量检测卡
WO2012065912A1 (de) 2010-11-17 2012-05-24 Karl-Heinz Kellner Automatenfähiger immunoassay für biogene amine
JP2012112785A (ja) 2010-11-24 2012-06-14 Tohoku Univ 透析膜の評価方法
JP5925026B2 (ja) * 2011-04-28 2016-05-25 アークレイ株式会社 クレアチニン測定用乾式試験片及びクレアチニン測定法
US20140038203A1 (en) * 2012-07-09 2014-02-06 Musc Foundation For Research Development Methods for detecting or predicting kidney disease
WO2015035155A1 (en) 2013-09-05 2015-03-12 Idexx Laboratories, Inc. Methods for detecting renal disease

Also Published As

Publication number Publication date
EP4295907A2 (en) 2023-12-27
JP6657096B2 (ja) 2020-03-04
DK3041576T3 (da) 2019-09-09
PT3041576T (pt) 2019-09-27
AU2014315063A1 (en) 2016-03-17
CY1123179T1 (el) 2021-10-29
EP3041576B1 (en) 2019-06-19
EP3480600A1 (en) 2019-05-08
CA3213810A1 (en) 2015-03-12
BR112016004839A8 (pt) 2020-02-11
AU2020256440A1 (en) 2020-11-12
CA2923140A1 (en) 2015-03-12
JP2020073927A (ja) 2020-05-14
CA2923140C (en) 2023-09-26
HRP20191569T1 (hr) 2019-11-29
JP2022070879A (ja) 2022-05-13
AU2014315063B2 (en) 2020-07-23
WO2015035155A1 (en) 2015-03-12
KR20210082567A (ko) 2021-07-05
MX2016002922A (es) 2016-11-07
KR102273028B1 (ko) 2021-07-02
RS59287B1 (sr) 2019-10-31
EP4295907A3 (en) 2024-03-13
EP3041576A1 (en) 2016-07-13
CN105705202A (zh) 2016-06-22
AU2020256440B2 (en) 2023-03-02
JP2016530532A (ja) 2016-09-29
EP3480600C0 (en) 2023-11-08
KR102412431B1 (ko) 2022-06-22
JP2024020376A (ja) 2024-02-14
MX2021006716A (es) 2021-07-15
US20220137059A1 (en) 2022-05-05
ES2746008T3 (es) 2020-03-04
EP3480600B1 (en) 2023-11-08
LT3041576T (lt) 2019-10-25
CN105705202B (zh) 2019-02-26
US20160187348A1 (en) 2016-06-30
EP3041576A4 (en) 2017-07-26
HUE045723T2 (hu) 2020-01-28
PL3041576T3 (pl) 2019-12-31
SI3041576T1 (sl) 2019-11-29
KR20160051887A (ko) 2016-05-11
US11035861B2 (en) 2021-06-15
NZ717554A (en) 2022-04-29

Similar Documents

Publication Publication Date Title
ES2969979T3 (es) Métodos para detectar enfermedad renal
WO2017079653A3 (en) Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals
FR3009387B1 (fr) Procede et dispositif d'analyse d'un echantillon biologique
BR112012028284A2 (pt) equipamento de insensibilização de animais para induzir a inconsciência e a insensibilidade substancialmente imediatas permitindo o processamento ou manuseio de um animal, método de insensibilização de um animal para induzir a inconsciência e a insensibilidade substancialmente imediatas permitindo o processamento ou manuseio de um animal, método de manusear e processar um animal, método de abater um animal e equipamento para insensibilização de animais para induzir a inconsciência e a insensibilidade substancialmente imediatas permitindo o processamento ou manuseio de um anima
FR3012219B1 (fr) Determination de la concentration d'un composant dans un fluide d'un animal par analyse spectroscopique d'un autre fluide
EP3182366A8 (en) Property measurement on a biological tissue sample
EP3101425A3 (en) Diagnostic testing for immunologic food sensitivity
WO2016022614A8 (en) Method for evaluating health and genetic predisposition of animals
EP2793102A3 (en) Information processing device
MX2023007778A (es) Metodos para detectar enfermedad renal.
Herrera-Dueñas et al. The relationship between house sparrow and the city: why urban populations are on decline
CY1122873T1 (el) Διαγνωστικη δοκιμη για την ανοσολογικη τροφικη ευαισθησια σε κυνας
Gagné et al. Testing Holling’s textural-discontinuity hypothesis.
MX2017010352A (es) Metodos para diagnosticar enfermedad valvular cronica.
ES1280644Y (es) Dispositivo portatil detector de parasitos en filetes de pescado.
Tolstel et al. Monitoring of the financial literacy growth of the population
Peña et al. Hair cortisol and acute phase proteins as stress markers in pigs
CN105934520A8 (zh) 作为生物标志物的共价键代谢物
TH1701000066A (th) ระบบและวิธีการสำหรับจัดให้มีคำแนะนำเกี่ยวกับสุขภาพโภชนาการ และ/หรือ ความสมบูรณ์แข็งแรงของสัตว์
RU2010108018A (ru) Способ оценки влияния садковой аквакультуры на состояние водной экосистемы
Carvalho et al. Genotype-environment interaction on the weights at 205 and 365 days of age in Nellore cattle in different regions of Brazil.
ES1249342Y (es) Dispositivo de recogida de heces de animales
Savić et al. Characteristics of Zackel sheep and exotic sheep breeds under sustainable management at the Sjenica-Pester plateau
Neumayer et al. Evaluation of a new portable blood cow side test for calcium
Banta et al. Prevalence of blood parasites in domestic dogs (Canis familiaris) and its association to their hematologic properties.